Kailasam MT - Search Results

1

O'Connor DT, Mahata SK, Taupenot L, Mahata M, Livsey Taylor CV, Kailasam MT, Ziegler MG, Parmer RJ. O'Connor DT, et al. Among authors: kailasam mt. Adv Exp Med Biol. 2000;482:377-88. doi: 10.1007/0-306-46837-9_31. Adv Exp Med Biol. 2000. PMID: 11192598 Review. No abstract available.

2

The catecholamine release-inhibitory "catestatin" region of chromogranin a: early decline in humans at genetic risk of hypertension.

O'Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara N, Parmer RJ. O'Connor DT, et al. Among authors: kailasam mt. Ann N Y Acad Sci. 2002 Oct;971:533-5. doi: 10.1111/j.1749-6632.2002.tb04520.x. Ann N Y Acad Sci. 2002. PMID: 12438176 No abstract available.

3

Chromogranin A in human hypertension. Influence of heredity.

Takiyyuddin MA, Parmer RJ, Kailasam MT, Cervenka JH, Kennedy B, Ziegler MG, Lin MC, Li J, Grim CE, Wright FA, et al. Takiyyuddin MA, et al. Among authors: kailasam mt. Hypertension. 1995 Jul;26(1):213-20. doi: 10.1161/01.hyp.26.1.213. Hypertension. 1995. PMID: 7607727

4

Cerebrospinal fluid chromogranin A is unchanged in Alzheimer dementia.

O'Connor DT, Kailasam MT, Thal LJ. O'Connor DT, et al. Among authors: kailasam mt. Neurobiol Aging. 1993 May-Jun;14(3):267-9. doi: 10.1016/0197-4580(93)90011-y. Neurobiol Aging. 1993. PMID: 8321395

5

Early decline in the catecholamine release-inhibitory peptide catestatin in humans at genetic risk of hypertension.

O'Connor DT, Kailasam MT, Kennedy BP, Ziegler MG, Yanaihara N, Parmer RJ. O'Connor DT, et al. Among authors: kailasam mt. J Hypertens. 2002 Jul;20(7):1335-45. doi: 10.1097/00004872-200207000-00020. J Hypertens. 2002. PMID: 12131530 Clinical Trial.

6

Diminished renal kallikrein responses to mineralocorticoid stimulation in African Americans: determinants of an intermediate phenotype for hypertension.

Wong CM, O'Connor DT, Martinez JA, Kailasam MT, Parmer RJ. Wong CM, et al. Among authors: kailasam mt. Am J Hypertens. 2003 Apr;16(4):281-9. doi: 10.1016/s0895-7061(03)00002-5. Am J Hypertens. 2003. PMID: 12670744

7

Divergent effects of dihydropyridine and phenylalkylamine calcium channel antagonist classes on autonomic function in human hypertension.

Kailasam MT, Parmer RJ, Cervenka JH, Wu RA, Ziegler MG, Kennedy BP, Adegbile IA, O'Connor DT. Kailasam MT, et al. Hypertension. 1995 Jul;26(1):143-9. doi: 10.1161/01.hyp.26.1.143. Hypertension. 1995. PMID: 7607717 Clinical Trial.

8

Factitious pheochromocytoma: novel mimickry by Valsalva maneuver and clues to diagnosis.

Kailasam MT, Parmer RJ, Stone RA, Shankel S, Kennedy BP, Ziegler MG, O'Connor DT. Kailasam MT, et al. Am J Hypertens. 1995 Jun;8(6):651-5. doi: 10.1016/0895-7061(95)00076-2. Am J Hypertens. 1995. PMID: 7662252 Clinical Trial.

9

Does lipophilicity of angiotensin converting enzyme inhibitors selectively influence autonomic neural function in human hypertension?

Wu RA, Kailasam MT, Cervenka JH, Parmer RJ, Kennedy BP, Ziegler MG, O'Connor DT. Wu RA, et al. Among authors: kailasam mt. J Hypertens. 1994 Nov;12(11):1243-7. J Hypertens. 1994. PMID: 7868871 Clinical Trial.

10

Expression of altered alpha2-adrenergic phenotypic traits in normotensive humans at genetic risk of hereditary (essential) hypertension.

Dao TT, Kailasam MT, Parmer RJ, Le HV, Le Verge R, Kennedy BP, Ziegler G, Insel PA, Wright FA, O'Connor DT. Dao TT, et al. Among authors: kailasam mt. J Hypertens. 1998 Jun;16(6):779-92. doi: 10.1097/00004872-199816060-00009. J Hypertens. 1998. PMID: 9663918

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

23 results

Search Page